BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 1995;5:199-206. [PMID: 8528266 DOI: 10.1097/00008571-199508000-00003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chiou T, Wang Y, Tzeng W. DT-diaphorase protects against menadione-induced oxidative stress. Toxicology 1999;139:103-10. [DOI: 10.1016/s0300-483x(99)00109-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 2004;382:115-44. [PMID: 15047100 DOI: 10.1016/S0076-6879(04)82008-1] [Cited by in Crossref: 176] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
3 Dinkova-kostova AT, Talalay P. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen11This paper is dedicated with admiration to the memory of Professor Lars Ernster, whose name will be identified forever with DT diaphorase. Free Radical Biology and Medicine 2000;29:231-40. [DOI: 10.1016/s0891-5849(00)00300-2] [Cited by in Crossref: 181] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
4 Bandmann O, Vaughan J, Holmans P, Marsden C, Wood N. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. The Lancet 1997;350:1136-9. [DOI: 10.1016/s0140-6736(97)03495-8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
5 Iskander K, Jaiswal AK. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chemico-Biological Interactions 2005;153-154:147-57. [DOI: 10.1016/j.cbi.2005.03.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
6 Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997;75:69-75. [PMID: 9000600 DOI: 10.1038/bjc.1997.11] [Cited by in Crossref: 221] [Cited by in F6Publishing: 205] [Article Influence: 8.8] [Reference Citation Analysis]
7 Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect. 1999;107 Suppl 1:37-47. [PMID: 10229705 DOI: 10.2307/3434470] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008;40:187-224. [PMID: 18464043 DOI: 10.1080/03602530801952864] [Cited by in Crossref: 123] [Cited by in F6Publishing: 88] [Article Influence: 8.8] [Reference Citation Analysis]
9 Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q, Wu K. Emerging roles of Nrf2 signal in non-small cell lung cancer. J Hematol Oncol 2016;9:14. [PMID: 26922479 DOI: 10.1186/s13045-016-0246-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
10 Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G. Low NAD(P)H: quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood. 2001;97:1422-1426. [PMID: 11222389 DOI: 10.1182/blood.v97.5.1422] [Cited by in Crossref: 103] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
11 Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 1999;107 Suppl 1:37-47. [PMID: 10229705 DOI: 10.1289/ehp.99107s137] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
12 Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J, Qin X, Li S. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol 2014;9:100. [PMID: 24884893 DOI: 10.1186/1746-1596-9-100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
13 Benhamou Anu Voho Christine Bouchardy Katja Mitrunen Pierre Dayer Ari Hirvonen S. Role of NAD(P)H:quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers. Biomarkers 2001;6:440-7. [PMID: 23886315 DOI: 10.1080/13547500110057399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Pey AL, Megarity CF, Timson DJ. FAD binding overcomes defects in activity and stability displayed by cancer-associated variants of human NQO1. Biochim Biophys Acta 2014;1842:2163-73. [PMID: 25179580 DOI: 10.1016/j.bbadis.2014.08.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
15 Pirmohamed M, Park B. Metabolic Models of Cytotoxicity. In: Woolf T, editor. Handbook of Drug Metabolism. CRC Press; 1999. pp. 443-76. [DOI: 10.1201/b13995-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002;100:3761-6. [PMID: 12393447 DOI: 10.1182/blood-2002-04-1152] [Cited by in Crossref: 121] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
17 Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241-56. [PMID: 12234692 DOI: 10.1016/s0169-5002(02)00107-1] [Cited by in Crossref: 99] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
18 Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA. High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol 1999;52:295-9. [PMID: 10748880 DOI: 10.1136/mp.52.5.295] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 3.0] [Reference Citation Analysis]
19 Shields PG. Tobacco Smoking, Harm Reduction, and Biomarkers. JNCI Journal of the National Cancer Institute 2002;94:1435-44. [DOI: 10.1093/jnci/94.19.1435] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
20 Yu H, Liu H, Wang LE, Wei Q. A functional NQO1 609C& gt; T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One. 2012;7:e30566. [PMID: 22272361 DOI: 10.1371/journal.pone.0030566] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Daly AK. Candidate gene case-control studies. Pharmacogenomics 2003;4:127-39. [DOI: 10.1517/phgs.4.2.127.22629] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
22 Iskander K, Li J, Han S, Zheng B, Jaiswal AK. NQO1 and NQO2 Regulation of Humoral Immunity and Autoimmunity. Journal of Biological Chemistry 2006;281:30917-24. [DOI: 10.1074/jbc.m605809200] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
23 Smith MT, Zhang L. Biomarkers of leukemia risk: benzene as a model. Environ Health Perspect 1998;106 Suppl 4:937-46. [PMID: 9703476 DOI: 10.1289/ehp.98106s4937] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
24 Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004;23:6500-6523. [PMID: 15322521 DOI: 10.1038/sj.onc.1207811] [Cited by in Crossref: 113] [Cited by in F6Publishing: 92] [Article Influence: 6.3] [Reference Citation Analysis]
25 Misra V, Klamut HJ, Rauth AM. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. Br J Cancer 1998;77:1236-40. [PMID: 9579828 DOI: 10.1038/bjc.1998.208] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
26 Ames BN, Elson-schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. The American Journal of Clinical Nutrition 2002;75:616-58. [DOI: 10.1093/ajcn/75.4.616] [Cited by in Crossref: 202] [Cited by in F6Publishing: 147] [Article Influence: 10.1] [Reference Citation Analysis]
27 Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res 2005;582:71-8. [PMID: 15781212 DOI: 10.1016/j.mrgentox.2004.12.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
28 Gresner P, Gromadzinska J, Wasowicz W. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 2007;57:1-25. [PMID: 17337085 DOI: 10.1016/j.lungcan.2007.02.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
29 Liu F, Luo L, Wei Y, Wang W, Li B, Yan L, Wen T. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Tumor Biol 2013;34:47-53. [DOI: 10.1007/s13277-012-0509-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
30 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
31 Iskander K, Barrios RJ, Jaiswal AK. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease. Cancer Res 2008;68:7915-22. [PMID: 18829548 DOI: 10.1158/0008-5472.CAN-08-0766] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
32 Begleiter A, Norman A, Leitao D, Cabral T, Hewitt D, Pan S, Grandis JR, Siegfried JM, El-Sayed S, Sutherland D, Ross DA, Kerr PD. Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncol 2005;41:927-33. [PMID: 16054862 DOI: 10.1016/j.oraloncology.2005.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
33 Danson S, Ward T, Butler J, Ranson M. DT-diaphorase: a target for new anticancer drugs. Cancer Treatment Reviews 2004;30:437-49. [DOI: 10.1016/j.ctrv.2004.01.002] [Cited by in Crossref: 133] [Cited by in F6Publishing: 119] [Article Influence: 7.4] [Reference Citation Analysis]
34 Thompson PA, Seyedi F, Lang NP, MacLeod SL, Wogan GN, Anderson KE, Tang YM, Coles B, Kadlubar FF. Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. Mutat Res 1999;424:263-74. [PMID: 10064866 DOI: 10.1016/s0027-5107(99)00024-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
35 Sacerdote C, Peluso M, Munnia A, Malaveille C, Vineis P. The choice of controls in a case-control study on WBC-DNA adducts and metabolic polymorphisms. Biomarkers 2000;5:307-13. [PMID: 23885983 DOI: 10.1080/135475000413854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Hirano M, Tanuma J, Hirayama Y, Ohyama M, Semba I, Wakusawa S, Shisa H, Hiai H, Kitano M. A speed congenic rat strain bearing the tongue cancer susceptibility locus Tscc1 from Dark-Agouti rats. Cancer Letters 2006;231:185-91. [DOI: 10.1016/j.canlet.2005.01.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers 2013;17:195-201. [PMID: 23397959 DOI: 10.1089/gtmb.2012.0278] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
38 Yuan W, Xu L, Chen W, Wang L, Fu Z, Pang D, Li D. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 2011;125:467-72. [PMID: 20526805 DOI: 10.1007/s10549-010-0966-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
39 Abu-Izneid T, Rauf A, Shariati MA, Khalil AA, Imran M, Rebezov M, Uddin MS, Mahomoodally MF, Rengasamy KRR. Sesquiterpenes and their derivatives-natural anticancer compounds: An update. Pharmacol Res 2020;161:105165. [PMID: 32835868 DOI: 10.1016/j.phrs.2020.105165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
40 Kadlubar FF, Anderson KE, Häussermann S, Lang NP, Barone GW, Thompson PA, MacLeod SL, Chou MW, Mikhailova M, Plastaras J, Marnett LJ, Nair J, Velic I, Bartsch H. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat Res 1998;405:125-33. [PMID: 9748537 DOI: 10.1016/s0027-5107(98)00129-8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
41 Culp S, Roberts D, Talaska G, Lang N, Fu P, Lay J, Teitel C, Snawder J, Von Tungeln L, Kadlubar F. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl–DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1997;378:97-112. [DOI: 10.1016/s0027-5107(97)00101-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
42 Lyn-Cook BD, Yan-Sanders Y, Moore S, Taylor S, Word B, Hammons GJ. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas. Cell Biol Toxicol. 2006;22:73-80. [PMID: 16532285 DOI: 10.1007/s10565-006-0156-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
43 Park S, Zhao H, Spitz MR, Barton Grossman H, Wu X. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2003;536:131-7. [DOI: 10.1016/s1383-5718(03)00041-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
44 Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer 1996;74:995-6. [PMID: 8826876 DOI: 10.1038/bjc.1996.477] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
45 Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The Molecular Epidemiology of Lung Cancer. Critical Reviews in Toxicology 2008;27:319-65. [DOI: 10.3109/10408449709089898] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
46 Smith MT, Wang Y, Skibola CF, Slater DJ, Nigro LL, Nowell PC, Lange BJ, Felix CA. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002;100:4590-3. [DOI: 10.1182/blood-2001-12-0264] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 5.2] [Reference Citation Analysis]
47 Ross D. Metabolic basis of benzene toxicity. European Journal of Haematology 1996;57:111-8. [DOI: 10.1111/j.1600-0609.1996.tb01656.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
48 Elbekai RH, Duke J, El-Kadi AO. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As(3+), Cd(2+) and Cr(6+). Cancer Lett 2007;246:54-62. [PMID: 16517059 DOI: 10.1016/j.canlet.2006.01.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
49 Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005;106:357-87. [PMID: 15922018 DOI: 10.1016/j.pharmthera.2005.01.001] [Cited by in Crossref: 371] [Cited by in F6Publishing: 334] [Article Influence: 23.2] [Reference Citation Analysis]
50 Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Beau MML, Smith MT. Prevalence of the Inactivating 609C→T Polymorphism in the NAD(P)H:Quinone Oxidoreductase (NQO1) Gene in Patients With Primary and Therapy-Related Myeloid Leukemia. Blood 1999;94:803-7. [DOI: 10.1182/blood.v94.2.803] [Cited by in Crossref: 205] [Article Influence: 8.9] [Reference Citation Analysis]
51 Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer 2001;34:177-83. [DOI: 10.1016/s0169-5002(01)00243-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
52 Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma. Mol Carcinog 1996;17:117-25. [DOI: 10.1002/(sici)1098-2744(199611)17:3<117::aid-mc3>3.0.co;2-c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Fan Y, Hu D, Feng B, Wang W. The NQO1 C609T polymorphism and hepatocellular carcinoma risk. Tumour Biol 2014;35:7343-50. [PMID: 24532470 DOI: 10.1007/s13277-014-1712-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
54 Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem. 1998;273:7382-7389. [PMID: 9516435 DOI: 10.1074/jbc.273.13.7382] [Cited by in Crossref: 192] [Cited by in F6Publishing: 179] [Article Influence: 8.0] [Reference Citation Analysis]
55 Gong X, Gutala R, Jaiswal AK. Quinone Oxidoreductases and Vitamin K Metabolism. Vitamin K. Elsevier; 2008. pp. 85-101. [DOI: 10.1016/s0083-6729(07)00005-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
56 Swinney R, Hsu S, Tomlinson G. Phase I and Phase II Enzyme Polymorphisms and Childhood Cancer: . Journal of Investigative Medicine 2006;54:303-20. [DOI: 10.2310/6650.2006.05062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
57 Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, Kiel S, Geddert H, Kandemir Y, Walter A, Willers R, Gabbert HE. Association betweenNAD(P)H: Quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer 2003;107:381-6. [DOI: 10.1002/ijc.11430] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
58 Pey AL, Megarity CF, Timson DJ. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Biosci Rep 2019;39:BSR20180459. [PMID: 30518535 DOI: 10.1042/BSR20180459] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
59 Carere A, Andreoli C, Galati R, Leopardi P, Marcon F, Rosati M, Rossi S, Tomei F, Verdina A, Zijno A, Crebelli R. Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2002;518:215-24. [DOI: 10.1016/s1383-5718(02)00108-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
60 von Schantz T, Bensch S, Grahn M, Hasselquist D, Wittzell H. Good genes, oxidative stress and condition-dependent sexual signals. Proc Biol Sci 1999;266:1-12. [PMID: 10081154 DOI: 10.1098/rspb.1999.0597] [Cited by in Crossref: 602] [Cited by in F6Publishing: 500] [Article Influence: 26.2] [Reference Citation Analysis]
61 Ikeda S, Sasazuki S, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Ohnami S, Sakamoto H, Yoshida T, Iwasaki M, Tsugane S. Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol 2008;103:1476-87. [PMID: 18510611 DOI: 10.1111/j.1572-0241.2008.01810.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
62 Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002;97:230-6. [PMID: 11774269 DOI: 10.1002/ijc.1589] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 5.1] [Reference Citation Analysis]
63 Li Z, Zhang Y, Jin T, Men J, Lin Z, Qi P, Piao Y, Yan G. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. BMC Cancer. 2015;15:207. [PMID: 25880877 DOI: 10.1186/s12885-015-1227-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
64 Guo S, Gao M, Li X, Li Y, Chu S, Zhu D, Niu W. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One 2012;7:e47939. [PMID: 23110137 DOI: 10.1371/journal.pone.0047939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
65 Puga A, Nebert DW, Mckinnon RA, Menon AG. Genetic Polymorphisms in Human Drug-Metabolizing Enzymes: Potential Uses of Reverse Genetics to Identify Genes of Toxicological Relevance. Critical Reviews in Toxicology 2008;27:199-222. [DOI: 10.3109/10408449709021619] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
66 Niwa Y, Hirose K, Nakanishi T, Nawa A, Kuzuya K, Tajima K, Hamajima N. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecol Oncol 2005;96:423-9. [PMID: 15661231 DOI: 10.1016/j.ygyno.2004.10.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
67 von Rahden BH, Stein HJ, Langer R, von Weyhern CW, Schenk E, Döring C, Siewert JR, Höfler H, Sarbia M. C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer 2005;113:506-8. [PMID: 15455349 DOI: 10.1002/ijc.20576] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
68 Smith MT. Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci U S A. 1999;96:7624-7626. [PMID: 10393869 DOI: 10.1073/pnas.96.14.7624] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 2.9] [Reference Citation Analysis]
69 Goldberg ZI, Cummings BJ, Chapman WB, Klamut HJ, Rauth AM. Role of a DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil, and mitomycin C. International Journal of Radiation Oncology*Biology*Physics 1998;42:331-4. [DOI: 10.1016/s0360-3016(98)00234-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol 2001;59:263-8. [PMID: 11160862 DOI: 10.1124/mol.59.2.263] [Cited by in Crossref: 163] [Cited by in F6Publishing: 152] [Article Influence: 7.8] [Reference Citation Analysis]
71 Luo S, Lei K, Xiang D, Ye K. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxid Med Cell Longev 2018;2018:9146528. [PMID: 30595797 DOI: 10.1155/2018/9146528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
72 Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Beau MML, Smith MT. Prevalence of the Inactivating 609C→T Polymorphism in the NAD(P)H:Quinone Oxidoreductase (NQO1) Gene in Patients With Primary and Therapy-Related Myeloid Leukemia. Blood 1999;94:803-7. [DOI: 10.1182/blood.v94.2.803.414k44_803_807] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
73 Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 2005;7:463-78. [PMID: 16170238 DOI: 10.1097/01.gim.0000177530.55043.c1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
74 Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer. 2001;33:133-141. [PMID: 11551408 DOI: 10.1016/s0169-5002(01)00182-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
75 Yadav U, Kumar P, Rai V. “ NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.”. Nutrition and Cancer 2018;70:557-68. [DOI: 10.1080/01635581.2018.1460674] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
76 Dhakshinamoorthy S, Long DJ 2nd, Jaiswal AK. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 2000;36:201-16. [PMID: 10842753 DOI: 10.1016/s0070-2137(01)80009-1] [Cited by in Crossref: 130] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]